KRAS and neoplasm: Strikingly, tumorigenesis was significantly accelerated in KPN KF mice with deletion of wild-type Kras, reflected by a significant reduction in overall survival based upon endpoint defined by clinical signs associated with tumour burden (Fig. 6a).